课题基金 / 基金详情

ATAZANAVIR AND RIFAMPIN IN HEALTHY HIV-SERONEGATIVE VOLUNTEERS

ATAZANAVIR AND RIFAMPIN IN HEALTHY HIV-SERONEGATIVE VOLUNTEERS
阿扎那韦和利福平在健康 HIV 血清阴性志愿者中的应用
批准号:
7605220
负责人:
ANDREW RICHARD ZOLOPA
金额:
$4.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30

项目摘要

项目成果

ANDREW RICHARD ZOLOPA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A5213 is an open-label, single-arm, pharmacokinetic (PK) interaction study of atazanavir (ATV) and rifampin (RIF) in healthy, HIV-seronegative volunteers. Safety and tolerability will be assessed during the study. Each subject who completes the study will have received study drugs for at least 27 days but no more than 37 days.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stanford AIDS Clinical Trials Unit
  • 批准号:
    7341111
  • 项目类别:
  • 资助金额:
    $81.66万
  • 财政年份:
    2007
  • 负责人:
    ANDREW RICHARD ZOLOPA
  • 依托单位:
ACTG 5001 ADULT AIDS CLINICAL TRIALS GROUP [ALLRT]
  • 批准号:
    7605164
  • 项目类别:
  • 资助金额:
    $11.38万
  • 财政年份:
    2007
  • 负责人:
    ANDREW RICHARD ZOLOPA
  • 依托单位:
Stanford AIDS Clinical Trials Unit
  • 批准号:
    8787342
  • 项目类别:
  • 资助金额:
    $17.86万
  • 财政年份:
    2007
  • 负责人:
    ANDREW RICHARD ZOLOPA
  • 依托单位:
A5142 A PHASE III, OPEN-LABEL COMPARISON OF LOPINAVIR/RITONAVIR (AIDS)
  • 批准号:
    7605179
  • 项目类别:
  • 资助金额:
    $0.57万
  • 财政年份:
    2007
  • 负责人:
    ANDREW RICHARD ZOLOPA
  • 依托单位: